Clinical Trials Browser

Phase 3 × NIH × Smoldering Multiple Myeloma × Clear all

NCT01169337 2025-11-25

Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma

Phase 3 Active not recruiting

226 enrolled 16 charts

Smoldering Multiple Myeloma

NCT00114101 2025-11-24

Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant

Phase 3 Active not recruiting

460 enrolled 11 charts

Smoldering Multiple Myeloma, Multiple Myeloma